Published in Am J Hum Genet on September 01, 1995
Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation. J Cell Biol (1998) 2.37
The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia. Am J Hum Genet (1997) 1.35
Allele-specific RNA silencing of mutant ataxin-3 mediates neuroprotection in a rat model of Machado-Joseph disease. PLoS One (2008) 1.34
Population based study of late onset cerebellar ataxia in south east Wales. J Neurol Neurosurg Psychiatry (2004) 1.11
Machado-Joseph disease/spinocerebellar ataxia type 3. Handb Clin Neurol (2012) 1.09
Mapping of a new autosomal dominant spinocerebellar ataxia to chromosome 22. Am J Hum Genet (1999) 1.07
Ancestral origins of the Machado-Joseph disease mutation: a worldwide haplotype study. Am J Hum Genet (2000) 1.06
High frequency of Machado-Joseph disease identified in southeastern Chinese kindreds with spinocerebellar ataxia. BMC Med Genet (2010) 0.94
A familial factor independent of CAG repeat length influences age at onset of Machado-Joseph disease. Am J Hum Genet (1996) 0.90
The genetic defect causing Huntington's disease: repeated in other contexts? Mol Med (1997) 0.90
Analysis of spinocerebellar ataxia types 1, 2, 3, and 6, dentatorubral-pallidoluysian atrophy, and Friedreich's ataxia genes in spinocerebellar ataxia patients in the UK. J Med Genet (1997) 0.86
Hereditary Cerebellar Ataxias: A Korean Perspective. J Mov Disord (2015) 0.83
Ataxin-3 protein and RNA toxicity in spinocerebellar ataxia type 3: current insights and emerging therapeutic strategies. Mol Neurobiol (2013) 0.81
Current understanding of the role of microRNAs in spinocerebellar ataxias. Cerebellum Ataxias (2014) 0.78
Investigation of the Josephin Domain protein-protein interaction by molecular dynamics. PLoS One (2014) 0.77
RNA interference mitigates motor and neuropathological deficits in a cerebellar mouse model of Machado-Joseph disease. PLoS One (2014) 0.76
Josephin Domain Structural Conformations Explored by Metadynamics in Essential Coordinates. PLoS Comput Biol (2016) 0.76
Alleviating neurodegeneration in Drosophila models of PolyQ diseases. Cerebellum Ataxias (2014) 0.75
Ataxin-3 promotes genome integrity by stabilizing Chk1. Nucleic Acids Res (2017) 0.75
The Toxic Effects of Pathogenic Ataxin-3 Variants in a Yeast Cellular Model. PLoS One (2015) 0.75
Thermodynamic and kinetic stability of the Josephin Domain closed arrangement: evidences from replica exchange molecular dynamics. Biol Direct (2017) 0.75
Genetic Screening for Spinocerebellar Ataxia Genes in a Japanese Single-Hospital Cohort. J Mov Disord (2017) 0.75
Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat Genet (1993) 7.97
CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat Genet (1994) 7.07
Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat Genet (1994) 3.90
Spinocerebellar ataxia type 5 in a family descended from the grandparents of President Lincoln maps to chromosome 11. Nat Genet (1994) 3.89
Evidence for a mechanism predisposing to intergenerational CAG repeat instability in spinocerebellar ataxia type I. Nat Genet (1993) 3.28
The gene for Machado-Joseph disease maps to human chromosome 14q. Nat Genet (1993) 2.18
Chromosomal assignment of the second locus for autosomal dominant cerebellar ataxia (SCA2) to chromosome 12q23-24.1. Nat Genet (1993) 2.03
Clinical, neuropathologic, and genetic studies of a large spinocerebellar ataxia type 1 (SCA1) kindred: (CAG)n expansion and early premonitory signs and symptoms. Neurology (1995) 1.97
Letter: Hereditary ataxia and HL-A. N Engl J Med (1974) 1.65
Spinocerebellar ataxia: variable age of onset and linkage to human leukocyte antigen in a large kindred. Ann Neurol (1988) 1.54
Molecular and clinical correlations in spinocerebellar ataxia type I: evidence for familial effects on the age at onset. Am J Hum Genet (1994) 1.38
Autosomal dominant cerebellar ataxia: clinical analysis of 263 patients from a homogeneous population in Holguín, Cuba. Neurology (1990) 1.30
Retinal degeneration characterizes a spinocerebellar ataxia mapping to chromosome 3p. Nat Genet (1995) 1.27
The gene for autosomal dominant cerebellar ataxia with pigmentary macular dystrophy maps to chromosome 3p12-p21.1. Nat Genet (1995) 1.26
Nigro-spino-dentatal degeneration with nuclear ophthalmoplegia. A unique and partially treatable clinico-pathological entity. J Neurol Sci (1972) 1.23
Autosomal dominant cerebellar phenotypes: the genotype has settled the issue. Neurology (1995) 1.21
Analysis of the SCA1 CAG repeat in a large number of families with dominant ataxia: clinical and molecular correlations. Ann Neurol (1995) 1.16
Effect of trinucleotide repeat length and parental sex on phenotypic variation in spinocerebellar ataxia I. Am J Hum Genet (1994) 1.13
The natural history of Machado-Joseph disease. An analysis of 138 personally examined cases. Can J Neurol Sci (1984) 0.97
The trinucleotide repeat expansion on chromosome 6p (SCA1) in autosomal dominant cerebellar ataxias. Brain (1994) 0.91
Autosomal dominant spinocerebellar ataxia: locus heterogeneity in a Nebraska kindred. Neurology (1992) 0.91
Family with dominantly inherited ataxia, amyotrophy, and peripheral sensory loss. Spinopontine atrophy or Machado-Joseph Azorean disease in another non-Portuguese family? Arch Neurol (1990) 0.82
Genetic linkage and spinocerebellar ataxia. Adv Neurol (1978) 0.80
Cranial computerized tomography and Marie's ataxia: a case report. Arch Neurol (1978) 0.79
Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell (1998) 6.24
Glutamine repeats and neurodegeneration. Annu Rev Neurosci (2000) 6.06
Major histocompatibility antigens: the human (HLA-A, -B, -C) and murine (H-2K, H-2D) class I molecules. Cell (1981) 5.81
Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol (1998) 5.42
DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell (1993) 4.57
Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell (1988) 4.47
Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nat Genet (1998) 4.27
An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8) Nat Genet (1999) 4.15
Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science (1998) 4.07
Identification of genes that modify ataxin-1-induced neurodegeneration. Nature (2000) 4.02
Spinocerebellar ataxia type 5 in a family descended from the grandparents of President Lincoln maps to chromosome 11. Nat Genet (1994) 3.89
Recruitment of a ROC1-CUL1 ubiquitin ligase by Skp1 and HOS to catalyze the ubiquitination of I kappa B alpha. Mol Cell (1999) 3.58
Evidence for a mechanism predisposing to intergenerational CAG repeat instability in spinocerebellar ataxia type I. Nat Genet (1993) 3.28
Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature (1997) 3.16
A familial Alzheimer's disease locus on chromosome 1. Science (1995) 3.14
Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science (1992) 3.14
Molecular cloning of a human histocompatibility antigen cDNA fragment. Proc Natl Acad Sci U S A (1980) 2.99
SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat. Cell (1995) 2.96
A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment. Proc Natl Acad Sci U S A (1987) 2.77
Assembly and maturation of HLA-A and HLA-B antigens in vivo. Cell (1979) 2.73
Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1. Nat Neurosci (2000) 2.72
Complete amino acid sequence of a papain-solubilized human histocompatibility antigen, HLA-B7. 2. Sequence determination and search for homologies. Biochemistry (1979) 2.71
Phyllosilicates on Mars and implications for early martian climate. Nature (2005) 2.66
Immediate and late clinical outcomes of carotid artery stenting in patients with symptomatic and asymptomatic carotid artery stenosis: a 5-year prospective analysis. Circulation (2001) 2.60
The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective. JAMA (1997) 2.45
Cloning and complete sequence of an HLA-A2 gene: analysis of two HLA-A alleles at the nucleotide level. J Immunol (1985) 2.43
Structure of crossreactive human histocompatibility antigens HLA-A28 and HLA-A2: possible implications for the generation of HLA polymorphism. Proc Natl Acad Sci U S A (1982) 2.36
Linkage map of the human major histocompatibility complex including the tumor necrosis factor genes. Proc Natl Acad Sci U S A (1987) 2.31
Carbohydrate moiety of HLA antigens. Antigenic properties and amino acid sequences around the site of glycosylation. J Biol Chem (1977) 2.30
Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. Proc Natl Acad Sci U S A (1999) 2.26
Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice. Neuron (1999) 2.25
The number of trait loci in late-onset Alzheimer disease. Am J Hum Genet (2000) 2.24
Measuring Friedreich ataxia: complementary features of examination and performance measures. Neurology (2006) 2.17
Neural transplantation in Huntington disease: long-term grafts in two patients. Neurology (2007) 2.15
Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice. Hum Mol Genet (2001) 2.13
Identification and characterization of the gene causing type 1 spinocerebellar ataxia. Nat Genet (1994) 2.13
Transfer and expression of three cloned human non-HLA-A,B,C class I major histocompatibility complex genes in mutant lymphoblastoid cells. Proc Natl Acad Sci U S A (1988) 2.12
Association of an apolipoprotein CII allele with familial dementia of the Alzheimer type. J Neurogenet (1987) 2.12
Late-onset hereditary axonal neuropathies. Neurology (2008) 2.09
Charcot-Marie-Tooth neuropathy type 1B is associated with mutations of the myelin P0 gene. Nat Genet (1993) 2.07
Mutations that impair a posttranscriptional step in expression of HLA-A and -B antigens. Proc Natl Acad Sci U S A (1985) 2.05
Purkinje cell expression of a mutant allele of SCA1 in transgenic mice leads to disparate effects on motor behaviors, followed by a progressive cerebellar dysfunction and histological alterations. J Neurosci (1997) 1.99
Comparison of amino acid sequences of two human histocompatibility antigens, HLA-A2 and HLA-B7: location of putative alloantigenic sites. Proc Natl Acad Sci U S A (1979) 1.94
Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol (1998) 1.93
CD4 and CD8 T cells have redundant but not identical roles in virus-induced demyelination. J Immunol (2000) 1.93
Isolation of HLA locus-specific DNA probes from the 3'-untranslated region. Proc Natl Acad Sci U S A (1984) 1.93
Biosynthesis and cell surface localization of nonglycosylated human histocompatibility antigens. J Immunol (1981) 1.91
Alzheimer's disease, apolipoprotein E4, and gender. JAMA (1994) 1.86
Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia. Arch Neurol (2001) 1.84
Beta-synuclein gene alterations in dementia with Lewy bodies. Neurology (2004) 1.82
Frontotemporal dementia and Parkinsonism linked to chromosome 17: a new group of tauopathies. Brain Pathol (1998) 1.80
Phenotypic variability of Gerstmann-Sträussler-Scheinker disease is associated with prion protein heterogeneity. J Neuropathol Exp Neurol (1998) 1.79
Measuring Friedreich ataxia: Interrater reliability of a neurologic rating scale. Neurology (2005) 1.79
Trinucleotide repeat expansion at the myotonic dystrophy locus reduces expression of DMAHP. Nat Genet (1997) 1.79
Familial frontotemporal dementia with ubiquitin-positive, tau-negative inclusions. Neurology (2000) 1.76
Mitochondrial protein synthesis: resistance to emetine and response to RNA synthesis inhibitors. Biochem Biophys Res Commun (1970) 1.74
The clinical and genetic spectrum of spinocerebellar ataxia 14. Neurology (2005) 1.74
Mutation of a putative protein degradation gene LITAF/SIMPLE in Charcot-Marie-Tooth disease 1C. Neurology (2003) 1.74
A gene responsible for cavernous malformations of the brain maps to chromosome 7q. Hum Mol Genet (1995) 1.74
Childhood sexual abuse and sexual transmission risk behaviour among HIV-positive men who have sex with men. AIDS Care (2003) 1.73
Phenotype of chromosome 14-linked familial Alzheimer's disease in a large kindred. Ann Neurol (1994) 1.73
Cerebellar leukoencephalopathy: most likely histiocytosis-related. Neurology (2008) 1.73
HLA-E. A novel HLA class I gene expressed in resting T lymphocytes. J Immunol (1988) 1.73
Potentiated transmission and prevention of further LTP by increased CaMKII activity in postsynaptic hippocampal slice neurons. Science (1994) 1.72
Inactivation of expression of gene 4 of mouse hepatitis virus strain JHM does not affect virulence in the murine CNS. Virology (2001) 1.71
The heavy chain of human histocompatibility antigen HLA-B7 contains an immunoglobulin-like region. Nature (1979) 1.70
Expression analysis of the ataxin-1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals. Nat Genet (1995) 1.70
Evidence for linkage of Charcot-Marie-Tooth neuropathy to the Duffy locus on chromosome 1. Am J Hum Genet (1982) 1.69
Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity. Euro Surveill (2014) 1.69
Intracellular processing of the N-terminal ORF 1a proteins of the coronavirus MHV-A59 requires multiple proteolytic events. Virology (1992) 1.67
The SCF(HOS/beta-TRCP)-ROC1 E3 ubiquitin ligase utilizes two distinct domains within CUL1 for substrate targeting and ubiquitin ligation. Mol Cell Biol (2000) 1.67
Genetic association studies: genes in search of diseases. Neurology (2001) 1.65
Close vaginal margins as a prognostic factor after radical hysterectomy. Gynecol Oncol (1998) 1.65
Report of the Second International Workshop on Human Chromosome 6. Genomics (1994) 1.64
Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region. Am J Hum Genet (1992) 1.63
The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1. Nature (1997) 1.61
Class I-like HLA genes map telomeric to the HLA-A2 locus in human cells. Nature (1983) 1.60
Mitochondrial protein synthesis: RNA with the properties of Eukaryotic messenger RNA. Proc Natl Acad Sci U S A (1973) 1.56
Late-onset SCA2: 33 CAG repeats are sufficient to cause disease. Neurology (2000) 1.56
Use of HLA loss mutants to analyse the structure of the human major histocompatibility complex. Nature (1982) 1.56
Spinocerebellar ataxia: localization of an autosomal dominant locus between two markers on human chromosome 6. Am J Hum Genet (1987) 1.55
Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. Am J Hum Genet (1996) 1.54
Dandy-Walker malformation: etiologic heterogeneity and empiric recurrence risks. Clin Genet (1985) 1.52
Translation and processing of mouse hepatitis virus virion RNA in a cell-free system. J Virol (1986) 1.51
Epidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patients. Ann Oncol (2005) 1.51
Gametic and somatic tissue-specific heterogeneity of the expanded SCA1 CAG repeat in spinocerebellar ataxia type 1. Nat Genet (1995) 1.51
Charcot-Marie-Tooth disease: data for genetic counseling relating age to risk. Clin Genet (1978) 1.51
Mapping of class I DNA sequences within the human major histocompatibility complex. Immunogenetics (1983) 1.50
A familial neuronal disease presenting as intestinal pseudoobstruction. Gastroenterology (1978) 1.50
Differential expression of HLA-E, HLA-F, and HLA-G transcripts in human tissue. Hum Immunol (1990) 1.48
Identification of putative polymerase gene product in cells infected with murine coronavirus A59. Virology (1987) 1.48
Can angle of progression in pregnant women before onset of labor predict mode of delivery? Ultrasound Obstet Gynecol (2012) 1.47
Mice lacking ataxin-1 display learning deficits and decreased hippocampal paired-pulse facilitation. J Neurosci (1998) 1.46
Serum amylase as a measure of salivary gland radiation damage. Hyperamylasaemia following fractionated exposure to 4 MV X rays delivered in high pressure oxygen, and effects of certain steroids on this response. Br J Radiol (1969) 1.45